The FDA also gave full approval to the Novavax COVID vaccine (Nuvaxovid) using this approach, approving it for those ages 65 ...

The US Food and Drug Administration has fully approved a new COVID vaccine option specifically targeting high-risk individuals, including seniors. The protein-based Nuvaxovid vaccine, produced by ...

Federal officials unveiled a rigorous regulatory approach to future COVID vaccines that could make it harder for many people ...

Details of the new rules for COVID-19 vaccine approvals were also outlined in an article published by The New England Journal ...

Agency leaders said there was evidence to justify approval only for older people and those with medical conditions. Many ...

The new framework unveiled May 20 says new COVID-19 shots should go only to those ages 65 and up or with underlying medical conditions.

U.S. regulators will no longer approve COVID booster shots for healthy adults and children without new studies, adding a ...

The agency will require manufacturers to conduct randomized, controlled trials to secure approval for healthy Americans.

No, this is not true. Vaccines undergo rigorous safety testing and are continuously monitored for adverse events.

FDA FLAGS SEVERE ITCH — Patients who stop using the oral allergy medicines cetirizine (Zyrtec) or levocetirizine (Xyzal) may ...

Previously granted Emergency Use Authorization, Nuvaxovid is now available for individuals over 12 years of age.

The agency will narrow its approval for updated coronavirus vaccines, marking a significant shift in the agency’s approach to ...